PRGO: Perrigo Company plc Company Profile & Statistics

About

Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business.

Info & Links

CEO

Patrick Lockwood Taylor

Headquarters

THE SHARP BUILDING, HOGAN PLACE
DUBLIN, L2 D02, IRELAND

Auditor

Ernst & Young LLP

Share holders

4,117

Employees

9,140

Perrigo Company plc Statistics

Valuation Measures

Market Capitalization²

3.49B

Enterprise Value

6.78B

Enterprise Value/EBITDA(ttm)

21.42

Price to Earnings Ratio(ttm)

11.02

Price to Sales(ttm)

0.85

Price to Book(mrq)

0.82

Price to Cash(ytd)

5.21

Profitability

Gross Margin(ttm)

36.06%

Operating Margin(ttm)

7.80%

Profit Margin(ttm)

-3.68%

Return on Equity(ttm)

7.38%

Return on Invested Capital(ttm)

-1.77%

Return on Assets(ttm)

3.18%

Income Statement

Revenue(ttm)

4.39B

Revenue Per Share(ttm)

32.19

Gross Profit(ttm)

1.58B

EBITDA(ttm)³

316.30M

Net Income Available to Common(ttm)

-159.70M

Diluted EPS(ttm)

-1.17

Share Statistics

Beta (5Y Monthly)

0.52

52-Week Change

-15.28%

S&P 500 52-Week Change

26.32%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

136.43M

Dividend Yield

4.02%

Float⁴

135.88M

% Held by Insiders

0.40%

% Held by Institutions

95.91%

Balance Sheet

Total Cash(mrq)

1.46B

Total Cash Per Share(mrq)

10.73

Total Debt(mrq)

4.75B

Total Debt/Equity(mrq)

104.10%

Current Ratio(mrq)

2.56%

Quick Ratio(mrq)

1.77%

Book Value Per Share(mrq)

33.45

Cash Flow

Operating Cash Flow Per Share(ytd)

0.37

Free Cash Flow(ytd)

3.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PRGO

Perrigo Company plc

Perrigo Company plc Profile